Glutamate: a new target in schizophrenia?
Wachtel
H
H
Department of Neuropsychopharmacology, Schering AG, Berlin, FRG.
Turski
L
L
D000818:Animals; D005971:Glutamates / Q000502:physiology*; D006801:Humans; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter / Q000378:metabolism / Q000502:physiology*; D012559:Schizophrenia / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology
D005971:Glutamates; D017470:Receptors, Glutamate; D016194:Receptors, N-Methyl-D-Aspartate; D017981:Receptors, Neurotransmitter